After being exposed to toxins from the LA fires, some firefighters are turning to a compounded breathing drug, but it's hard ...
A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another lawsuit against the U.S. Food and Drug Administration (FDA). This time, ...
The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...
GlobalData on MSN18d
Semaglutide shortage ends as FDA sets deadline for compoundersWith Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed – for now.
Scott Brunner, CEO of the Alliance for Pharmacy Compounding, which represents compounding pharmacists and technicians, questioned whether the FDA took into account the number of patients who w ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results